XML 12 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2022
Nov. 09, 2022
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2022  
Entity File Number 001-37526  
Entity Registrant Name Zynerba Pharmaceuticals, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 26-0389433  
Entity Address, Address Line One 80 W. Lancaster Avenue  
Entity Address, Address Line Two Suite 300  
Entity Address, City or Town Devon  
Entity Address, State or Province PA  
Entity Address, Postal Zip Code 19333  
City Area Code 484  
Local Phone Number 581-7505  
Title of 12(b) Security Common Stock, $0.001 par value per share  
Trading Symbol ZYNE  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   47,062,711
Entity Central Index Key 0001621443  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Amendment Flag false